Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
protease inhibitor |
| gptkbp:approvedBy |
gptkb:FDA
1997 |
| gptkbp:ATCCode |
gptkb:J05AE04
|
| gptkbp:brand |
gptkb:Viracept
|
| gptkbp:CASNumber |
159989-64-7
|
| gptkbp:developedBy |
1990s
|
| gptkbp:discoveredBy |
gptkb:Agouron_Pharmaceuticals
|
| gptkbp:eliminationHalfLife |
3.5-5 hours
|
| gptkbp:hasMolecularFormula |
C32H45N3O4S
|
| https://www.w3.org/2000/01/rdf-schema#label |
nelfinavir
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits HIV-1 protease
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea rash |
| gptkbp:usedFor |
HIV infection
|
| gptkbp:bfsParent |
gptkb:azithromycin
|
| gptkbp:bfsLayer |
6
|